1 Min Read
April 18 (Reuters) - Chr Hansen Holding A/S:
* SAYS ENTERS PARTNERSHIP WITH OF ORAL IMMUNOTHERAPY DEVELOPER PROTA THERAPEUTICS TO DEVELOP TREATMENT FOR PEANUT ALLERGIES Further company coverage: (Copenhagen newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.